Upgrade to SI Premium - Free Trial

Eli Lilly stock gains on new weight-loss drug study results, Novo Nordisk down

August 1, 2024 7:48 AM
Shares in Eli Lilly (NYSE: LLY) climbed higher in premarket trading Thursday after the pharma giant’s blockbuster drug Zepbound has ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Hot List Momentum Movers

Next Articles